ValuEngine upgraded shares of Addus Homecare (NASDAQ:ADUS) from a buy rating to a strong-buy rating in a research note released on Tuesday.

ADUS has been the topic of several other research reports. Robert W. Baird restated a hold rating and set a $65.00 price target on shares of Addus Homecare in a report on Wednesday, August 8th. Zacks Investment Research upgraded Addus Homecare from a hold rating to a strong-buy rating and set a $60.00 price target on the stock in a report on Tuesday, May 8th. Jefferies Financial Group initiated coverage on Addus Homecare in a report on Tuesday, August 21st. They set a buy rating and a $75.00 price target on the stock. Finally, BidaskClub upgraded Addus Homecare from a buy rating to a strong-buy rating in a report on Saturday, June 23rd. One analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of Buy and an average price target of $70.33.

NASDAQ:ADUS opened at $66.35 on Tuesday. Addus Homecare has a fifty-two week low of $30.95 and a fifty-two week high of $71.78. The firm has a market cap of $828.94 million, a P/E ratio of 45.76, a P/E/G ratio of 2.60 and a beta of -0.38. The company has a debt-to-equity ratio of 0.53, a quick ratio of 3.09 and a current ratio of 3.09.

Addus Homecare (NASDAQ:ADUS) last released its quarterly earnings results on Tuesday, August 7th. The company reported $0.50 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.51 by ($0.01). Addus Homecare had a net margin of 3.43% and a return on equity of 10.45%. The company had revenue of $131.24 million for the quarter, compared to analysts’ expectations of $127.81 million. sell-side analysts forecast that Addus Homecare will post 1.67 EPS for the current year.

In other Addus Homecare news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of the stock in a transaction on Monday, August 20th. The stock was sold at an average price of $59.00, for a total value of $60,459,247.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 34.80% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in ADUS. BlackRock Inc. increased its stake in Addus Homecare by 31.9% in the second quarter. BlackRock Inc. now owns 585,281 shares of the company’s stock worth $33,505,000 after purchasing an additional 141,597 shares during the period. Renaissance Technologies LLC increased its stake in Addus Homecare by 191.1% in the second quarter. Renaissance Technologies LLC now owns 183,700 shares of the company’s stock worth $10,517,000 after purchasing an additional 120,600 shares during the period. Acadian Asset Management LLC purchased a new stake in Addus Homecare in the second quarter worth $4,690,000. ClariVest Asset Management LLC purchased a new stake in Addus Homecare in the second quarter worth $3,781,000. Finally, Millennium Management LLC increased its stake in Addus Homecare by 488.0% in the second quarter. Millennium Management LLC now owns 67,137 shares of the company’s stock worth $3,844,000 after purchasing an additional 55,719 shares during the period. Institutional investors and hedge funds own 84.81% of the company’s stock.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Recommended Story: How are Outstanding Shares Different from Authorized Shares?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.